Get startedLog in
    Picture of Regulus Therapeutics logo

    RGLS — Regulus Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    All News

    Brief: Regulus Therapeutics Reports Second Quarter 2022 Financial Results

    Picture of Regulus Therapeutics logoRegulus Therapeutics
    11/08/2022 22:16
    Aug 11 (Reuters) - Regulus Therapeutics Inc  RGLS.O :
    * REGULUS THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND RECENT UPDATES
    * REGULUS THERAPEUTICS INC - AS OF JUNE 30, 2022, REGULUS
HAD
$47.5 MILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES
    * REGULUS THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.50

Source text for Eikon:  ID:nPnbrpHp8a 
Further company coverage:  RGLS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Regulus Therapeutics

    See all news